The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin - Concepedia

Concepedia

Publication | Open Access

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin

DOI Full Paper Access

339

Citations

58

References

2021

Year

Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, Antônio Barbieri, M. Monti, Andreina Carbone, Andrea Paccone, Lucia Altucci, Mariarosaria Conte, Maria Laura Canale,

Cardiovascular Diabetology

References

	Year	Citations

Page 1